Please login to the form below

Not currently logged in
Email:
Password:

BMS promotes Paul Biondi to head of business development

He willnow lead the development of its strategic partnerships

Bristol-Myers Squibb BMS Paul BiondiBristol-Myers Squibb has promoted Paul Biondi to senior VP, head of business development, a role that will see him lead the development of strategic partnerships.

Biondi will also be tasked with pursuing scientific innovations across commercial, development, discovery and technology platforms to complement the company's internal R&D pipeline.

Biondi said: “Business development is a key component of Bristol-Myers Squibb's strategy, and has strengthened and diversified our portfolio for long-term growth. 

“We have been successful in executing transactions that make sense strategically, scientifically and economically for our company and partners. I look forward to leading this high-performing team and continuing our pursuit of collaborative partnerships and scientific innovation to help patients.”

He has served at BMS for more than 10 years and was most recently senior vice president, head of R&D Operations.

In his new position Biondi will report to BMS' chief financial officer Charlie Bancroft.

“Paul has established himself as a dynamic and collaborative leader at Bristol-Myers Squibb and made significant contributions over the past 10 years to our success in R&D and business development,” said Bancroft.

“With deep knowledge of our R&D strategy and portfolio, strong business expertise and understanding of the healthcare landscape, Paul is the ideal leader to continue our pursuit of external innovation that helps Bristol-Myers Squibb develop and deliver transformational medicines for patients with serious diseases.”

16th October 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...
Brain scan
Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...

Infographics